2001
DOI: 10.1093/biostatistics/2.2.173
|View full text |Cite
|
Sign up to set email alerts
|

Referent sampling, family history and relative risk: the role of length-biased sampling

Abstract: Familial risk of disease is often assessed using case control studies based on referent databases. A referent database is a collection of family histories of cases typically assembled as a result of one family member being diagnosed with disease. This sampling scheme is equivalent to sampling families proportional to their size. The larger the family, the greater the probability of finding the family in the referent registry. This phenomena is known as length-biased sampling. The consequence of this kind of sa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
8
0

Year Published

2003
2003
2013
2013

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(8 citation statements)
references
References 12 publications
0
8
0
Order By: Relevance
“…Retrospective studies may yield overstated effect estimates for family size; in these studies, the probability of recruiting a patient is positively associated with family size. Because the probability of having an affected family member also depends on the number of relatives a patient has, the proportion of patients with affected relatives can be higher than the proportion of controls with affected relatives even in the absence of familial clustering of prostate carcinoma 62–64. In prospective studies, however, this “length bias sampling” does not occur, as cases originate from a predefined cohort that is not dependent on family size.…”
Section: Discussionmentioning
confidence: 99%
“…Retrospective studies may yield overstated effect estimates for family size; in these studies, the probability of recruiting a patient is positively associated with family size. Because the probability of having an affected family member also depends on the number of relatives a patient has, the proportion of patients with affected relatives can be higher than the proportion of controls with affected relatives even in the absence of familial clustering of prostate carcinoma 62–64. In prospective studies, however, this “length bias sampling” does not occur, as cases originate from a predefined cohort that is not dependent on family size.…”
Section: Discussionmentioning
confidence: 99%
“…Because of lead‐time bias in cancer‐screening trials, a tumor may be detected according to its individual size (Ghosh, 2008). More examples of size‐biased sampling have been observed in industrial fiber testing (Cox, 1969), family studies of rare genetic diseases (Patil and Rao, 1978; Davidov and Zelen; 2001), etiological studies (Simon, 1980), and chronic/early disease modeling (Zelen, 2005).…”
Section: Introductionmentioning
confidence: 99%
“…For example, in case-control studies for assessing the role of FH, one assembles a registry by collecting FHs from individuals diagnosed with the disease and then compares them with a control group, whose FHs are also collected [16]. This registry is not a random sample of families or individuals from the underlying population, since families with multiple cases could be overrepresented (ascertainment bias).…”
Section: Discussionmentioning
confidence: 99%